ELIGARD 22.5mg

leuprolide acetate · HanAll BioPharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ELIGARD 22.5mg, covering 2015-09-23 to 2015-09-23. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer [Phase 4]